Development of a fluorescent high throughput assay for tau aggregation

Assay and Drug Development Technologies

Volumn 2, Issue 6, 2004, Pages 609-619

  Liu, Min ^a   Ni, Jake ^a   Kosik, Kenneth S ^b   Yeh, Li An ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DIMER; FATTY ACID; FLUORESCENT DYE; LIGAND; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN AGGREGATION INHIBITOR; PROTEIN TAU; RECOMBINANT PROTEIN; TETRAMER; UNCLASSIFIED DRUG;

ARTICLE; BINDING COMPETITION; DRUG IDENTIFICATION; FLUORESCENCE SPECTROSCOPY; FLUORESCENT RESONANCE ENERGY TRANSFER; HIGH THROUGHPUT SCREENING; IMMUNOCHEMISTRY; PROTEIN AGGREGATION; PROTEIN CROSS LINKING; PROTEIN DETERMINATION; PROTEIN INDUCTION;

ARACHIDONIC ACID; BINDING, COMPETITIVE; CROSS-LINKING REAGENTS; DIMETHYL SULFOXIDE; DNA, COMPLEMENTARY; DRUG EVALUATION, PRECLINICAL; ESCHERICHIA COLI; FATTY ACIDS; FLUORESCENT DYES; HUMANS; KINETICS; PROTEIN BINDING; RECOMBINANT PROTEINS; SPECTROMETRY, FLUORESCENCE; TAU PROTEINS;

EID: 14644403123     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2004.2.609     Document Type: Article

References (24)

1. Tolnay M, Probst A: Tau protein pathology in Alzheimer's 0disease and related disorders. Neuropathol Appl Neurobiol 1999;25:171-187.
2. Kosik KS: Tau: structure and function. In: Brain Microtubule Associated Proteins. Arila J, Brandt R, Kosik KS, (eds.), pp. 43-52. Harvard Academic, Amsterdam, 1997.
3. Kosik KS, Orecchio LD, Bakalis S, Neve RL: Developmentally regulated expression of specific tau sequences. Neuron 1989;2:1389-1397.
4. Lee VM, Goedert M, Trojanowski JQ: Neurodegenerative tauopathies. Annu Rev Neurosci 2001;24:1121-1159.
5. Perez M, Valpuesta JM, Medina M, Montejo de Garcini E, Avila J: Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. J Neurochem 1996;67:1183-1190.
6. Goedert M, Jakes R, Spillantini MG, Hasegawa M, Smith MJ, Crowther RA: Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 1996;383:550-553.
7. Kampers T, Friedhoff P, Biernat J, Mandelkow EM, Mandelkow E: RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett 1996;399:344-349.
8. Wilson DM, Binder LI: Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. Am J Pathol 1997;150:2181-2195.
9. King ME, Ahuja V, Binder LI, Kuret J: Ligand-dependent tau filament formation: implications for Alzheimer's disease progression. Biochemistry 1999;38:14851-14859.
10. Barghorn S, Mandelkow E: Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. Biochemistry 2002;41:14885-14896.
11. Wischik CM, Novak M, Thogersen HC, Edwards PC, Runswick MJ, Jakes R, Walker JE, Milstein C, Roth M, Klug A: Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A 1988;85:4506-4510.
12. Novak M, Kabat J, Wischik CM: Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J 1993;12: 365-370.
13. Crowther RA: Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc Natl Acad Sci U S A 1991;88:2288-2292.
14. Friedhoff P, Schneider A, Mandelkow EM, Mandelkow E: Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. Biochemistry 1998;37:10223-10230.
15. Perez M, Arrasate M, Montejo De Garcini E, Munoz V, Avila J: In vitro assembly of tau protein: mapping the regions involved in filament formation. Biochemistry 2001; 40:5983-5991.
16. Ahn JS, Musacchio A, Mapelli M, Ni J, Scinto L, Stein R, Kosik KS, Yeh LA: Development of an assay to screen for inhibitors of tau phosphorylation by cdk5. J Biomol Screen 2004;9:122-131.
17. Lee G, Neve RL, Kosik KS: The microtubule binding domain of tau protein. Neuron 1989;2:1615-1624.
18. King ME, Gamblin TC, Kuret J, Binder LI: Differential assembly of human tau isoforms in the presence of arachidonic acid. J Neurochem 2000;74:1749-1757.
19. Paudel HK, Li W: Heparin-induced conformational change in microtubule-associated protein Tau as detected by chemical cross-linking and phosphopeptide mapping. J Biol Chem 1999;274:8029-8038.
20. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assay. J Biomol Screen 1999;4:67-73.
21. von Bergen M, Friedhoff P, Biernat J, Heberle J, Mandelkow EM, Mandelkow E: Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. 0Proc Natl Acad Sci U S A 2000;97:5129-5134.
22. Gamblin TC, Berry RW, Binder LI: Tau polymerization: role of the amino terminus. Biochemistry 2003;42:2252-2257.
23. Chirita C, Kuret J: Evidence for an intermediate in tau filament formation. Biochemistry 2004;43:1704-1714.
24. Li L, von Bergen M, Mandelkow EM, Mandelkow E: Structure, stability, and aggregation of paired helical filaments from tau protein and FTDP-17 mutants probed by tryptophan scanning mutagenesis. J Biol Chem 2002;277: 41390-41400.